Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUL Ocular Therapeutix

未开盘 11-15 16:00:00 EST

9.16

-0.76

-7.66%

盘后9.16

+0.00+0.02%

19:54 EST

最高10.03	最低9.15	成交量133.06万
今开10.03	昨收9.92	日振幅8.92%
总市值14.40亿	流通市值10.98亿	总股本1.57亿
成交额1,249万	换手率1.11%	流通股本1.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":9.16,"timestamp":1731704400000,"preClose":9.92,"halted":0,"volume":1330624,"hourTrading":{"tag":"盘后","latestPrice":9.1616,"preClose":9.16,"latestTime":"19:54 EST","volume":64483,"amount":590742.584,"timestamp":1731718494191},"delay":0,"floatShares":119900644,"shares":157217427,"eps":-1.26918,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.76,"latestTime":"11-15 16:00:00 EST","open":10.03,"high":10.03,"low":9.145,"amount":12486623.518464,"amplitude":0.089214,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.26918,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1406260800000,"adjPreClose":9.92,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":10.03,"preClose":9.92,"latestTime":"09:11 EST","volume":114,"amount":1115.299962,"timestamp":1731679867782},"postHourTrading":{"tag":"盘后","latestPrice":9.1616,"preClose":9.16,"latestTime":"19:54 EST","volume":64483,"amount":590742.584,"timestamp":1731718494191},"volumeRatio":1.4536209759386602,"impliedVol":0.7795,"impliedVolPercentile":0.348},"requestUrl":"/m/hq/s/OCUL/wiki","defaultTab":"wiki","newsList":[{"id":"2483698307","title":"Ocular Therapeutix, Inc.盘中异动 快速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483698307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483698307?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:07","pubTimestamp":1731690445,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日01时07分，Ocular Therapeutix, Inc.股票出现波动，股价大幅下挫5.04%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为3.58%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Tc Biopharm  Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为4343.35%、657.19%、481.04%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 ，振幅分别为134.58%、129.73%、110.59%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116010725a23bad3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116010725a23bad3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2483802113","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大跌5.42%报10.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483802113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483802113?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:44","pubTimestamp":1731595440,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时44分，Ocular Therapeutix, Inc.股票出现异动，股价快速下跌5.42%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1822.43%、26.28%、18.18%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Elevai Labs, Inc.，振幅分别为75.00%、38.76%、38.46%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224401abc16184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224401abc16184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2482714924","title":"Ocular Therapeutix Inc  预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482714924","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482714924?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:46","pubTimestamp":1731383180,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Inc  预计每股亏损 24 美分 - 财报前瞻Ocular Therapeutix Inc OCUL.OQ OCUL.O预计将在11月13日公布截至2024年9月30日的季度收入报告。LSEG 分析师对 Ocular Therapeutix Inc 的平均预期是每股亏损 24 美分。华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 16.00 美元，高于其上次收盘价 10.96 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4S3MJ0BK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2481612556","title":"Ocular Therapeutix Inc    预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481612556","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481612556?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:03","pubTimestamp":1730869422,"startTime":"0","endTime":"0","summary":"   * Ocular Therapeutix Inc    预计将在11月7日公布截至2024年9月30日的业绩报告() 时显示季度收入增长。* 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于马萨诸塞州贝德福德的公司的营收有望从去年同期的1508万美元增长13.7%，达到1714.1万美元。* LSEG 分析师对 Ocular Therapeutix Inc 的平均预期是每股亏损 24 美分。* 华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 16.00 美元，高于其上次收盘价 10.57 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ocular Therapeutix Inc    预计每股亏损 24 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2480362584","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速下挫5.68%报9.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480362584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480362584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730687,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Ocular Therapeutix, Inc.股票出现波动，股价大幅跳水5.68%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为231.37%、123.83%、40.42%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Cns Pharmaceuticals, Inc.，振幅分别为29.83%、11.39%、7.55%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223127a215491a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223127a215491a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2478489823","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大涨5.02%报11.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478489823","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478489823?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:45","pubTimestamp":1730123143,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时45分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.02%。截至发稿，该股报11.70美元/股，成交量7.9258万股，换手率0.05%，振幅3.86%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821454398e3ed29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821454398e3ed29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2477552493","title":"Ocular Therapeutix, Inc.盘中异动 下午盘大幅跳水5.04%报10.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477552493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477552493?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:54","pubTimestamp":1729706092,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时54分，Ocular Therapeutix, Inc.股票出现波动，股价快速下跌5.04%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1864.39%、1531.51%、505.24%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.，振幅分别为109.26%、71.86%、68.32%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024015453971a1dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024015453971a1dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2475913037","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475913037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475913037?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:09","pubTimestamp":1729087785,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时09分，Ocular Therapeutix, Inc.股票出现波动，股价急速拉升5.08%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为4543.00%、923.18%、186.33%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为623.68%、279.52%、121.40%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622094598e3cc9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622094598e3cc9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2475312289","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.11%报10.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475312289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475312289?lang=zh_cn&edition=full","pubTime":"2024-10-15 03:04","pubTimestamp":1728932660,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日03时04分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.11%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。其相关个股中，Tevogen Bio Holdings Inc.、Bright Minds Biosciences Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Aditxt, Inc.、Rani Therapeutics Holdings, Inc.、Bright Minds Biosciences Inc.较为活跃，换手率分别为314.36%、164.64%、144.05%，振幅较大的相关个股有Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为149.47%、131.54%、119.48%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015030421971a02bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015030421971a02bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2474710097","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474710097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474710097?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:12","pubTimestamp":1728655961,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时12分，Ocular Therapeutix, Inc.股票出现波动，股价快速拉升5.53%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为180.06%、101.65%、18.61%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tc Biopharm  Plc C/Wts 10/02/2028 、Nutriband Inc C/Wts ，振幅分别为57.84%、45.00%、44.64%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011221242ab6974ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011221242ab6974ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2473995143","title":"Ocular Therapeutix, Inc.盘中异动 急速上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473995143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473995143?lang=zh_cn&edition=full","pubTime":"2024-10-05 02:16","pubTimestamp":1728065784,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日02时16分，Ocular Therapeutix, Inc.股票出现波动，股价急速拉升5.25%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Seelos Therapeutics, Inc.较为活跃，换手率分别为17345.69%、74.77%、68.09%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为69.59%、58.64%、56.26%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100502162598e3aa64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100502162598e3aa64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2469127675","title":"Ocular Therapeutix, Inc.盘中异动 临近收盘大幅跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469127675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469127675?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:53","pubTimestamp":1727121211,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时53分，Ocular Therapeutix, Inc.股票出现波动，股价急速跳水5.01%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为2.71%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Serina Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为346.78%、106.69%、82.85%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Serina Therapeutics, Inc.，振幅分别为74.90%、57.08%、50.30%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092403533198e387ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092403533198e387ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2460303720","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460303720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460303720?lang=zh_cn&edition=full","pubTime":"2024-08-19 22:28","pubTimestamp":1724077728,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日22时28分，Ocular Therapeutix, Inc.股票出现异动，股价大幅上涨5.06%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Alzamend Neuro, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tonix Pharmaceuticals Holding Corp.涨幅较大，Alzamend Neuro, Inc.、Tonix Pharmaceuticals Holding Corp.、Cingulate Inc.较为活跃，换手率分别为5335.94%、690.19%、575.51%，振幅较大的相关个股有Alzamend Neuro, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为405.90%、87.61%、48.92%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081922284897199284&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081922284897199284&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2460249167","title":"Ocular Therapeutix, Inc.2024财年第二财季实现净利润-43.78百万美元，同比减少111.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460249167","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460249167?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824026,"startTime":"0","endTime":"0","summary":"8月17日，Ocular Therapeutix, Inc.公布财报，公告显示公司2024财年第二财季净利润为-43.78百万美元，同比减少111.70%；其中营业收入为16.44百万美元，同比增加8.23%，每股基本收益为-0.26美元。从资产负债表来看，Ocular Therapeutix, Inc.总负债1.39亿美元，其中短期债务1.66百万美元，资产负债比为3.72，流动比率为0.17。机构评级：截至2024年8月17日，当前有8家机构对Ocular Therapeutix, Inc.目标价做出预测，其中目标均价为14.88美元，其中最低目标价为11.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000359959f2b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000359959f2b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2459479732","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479732","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479732?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:03","pubTimestamp":1723734221,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时03分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.01%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6312.48%、2040.73%、569.92%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230341ab5ddbbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230341ab5ddbbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2458349839","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458349839","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458349839?lang=zh_cn&edition=full","pubTime":"2024-08-09 00:09","pubTimestamp":1723133350,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日00时09分，Ocular Therapeutix, Inc.股票出现波动，股价急速下挫5.02%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为2.56%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Conduit Pharmaceuticals Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Oragenics Inc.较为活跃，换手率分别为389.88%、290.48%、184.66%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Oragenics Inc.、Fibrobiologics, Inc.，振幅分别为111.39%、54.41%、45.58%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900091096825388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080900091096825388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"1113960349","title":"异动解读 | Ocular Therapeutix公布季度业绩 股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113960349","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113960349?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:50","pubTimestamp":1723042230,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix公司今日股价大涨5.07%,引发市场关注。公司刚刚公布了截至6月底的季度财报。\n\n财报显示,公司本季度营收同比增长8.3%至1644万美元,高于分析师预期的1582万美元。但由于研发和运营成本的增加,公司本季度亏损4378万美元,调整后每股亏损26美分,与去年同期持平,也未达到分析师预期的每股亏损22美分。\n\n尽管业绩未达预期,但分析师对该公司前景仍持乐观态度。目前分析师对该公司股票的平均评级为\"强力买入\",12个月目标价中位数为14.5美元,较目前股价有一定上涨空间。分析师认为,公司在眼科药物领域的创新产品将推动未来业绩增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2457884977","title":"Ocular Therapeutix Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457884977","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457884977?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:34","pubTimestamp":1723037658,"startTime":"0","endTime":"0","summary":"   * Ocular Therapeutix Inc   报告，在截至6月底的季度里，调整后每股亏损26美分，与去年同期持平。七位分析师对该季度的平均预期是每股亏损 22 美分。华尔街预期为每股-25美分至-14美分。* 营收同比增长 8.3%，达到 1644 万美元；分析师预期为 1582 万美元。* Ocular Therapeutix Inc公布的本季度每股收益为亏损26美分。* 该公司本季度亏损 4,378 万美元。* Ocular Therapeutix Inc 本季度股价上涨了 15.4%，今年迄今为止上涨了 76.9%。华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 14.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ocular Therapeutix Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"1103145676","title":"异动解读 | Ocular Therapeutix股价大涨5.57% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1103145676","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103145676?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:30","pubTimestamp":1722972645,"startTime":"0","endTime":"0","summary":"北京时间2024年8月7日,生物技术公司Ocular Therapeutix股价盘中大涨5.57%,报收7.84美元/股,成交量和振幅均较大。分析人士认为,Ocular Therapeutix股价大涨或与机构投资者对公司前景的看好有关。更重要的是,目前所有8家评级机构均给予该股买入评级,反映出机构对公司长期发展前景的乐观预期。作为一家专注于眼科疾病治疗的生物技术公司,Ocular Therapeutix拥有多个在研管线产品,包括Dextenza、OTX-TIC、OTX-TKI和OTX-IVT等,有望为公司带来新的收入增长点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2457003833","title":"Ocular Therapeutix, Inc.盘中异动 快速拉升5.23%报7.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457003833","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457003833?lang=zh_cn&edition=full","pubTime":"2024-08-07 03:22","pubTimestamp":1722972174,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日03时22分，Ocular Therapeutix, Inc.股票出现异动，股价快速拉升5.23%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1444.80%、1402.74%、559.32%，振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为168.52%、81.76%、78.49%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080703225498e34c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080703225498e34c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocutx.com","stockEarnings":[{"period":"1week","weight":-0.1748},{"period":"1month","weight":-0.2014},{"period":"3month","weight":0.1295},{"period":"6month","weight":0.4846},{"period":"1year","weight":3.4038},{"period":"ytd","weight":1.0538}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家生物制药公司，致力于对使用该公司专有的水凝胶技术平台眼部疾病和病症的创新疗法的开发和商业化。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的主导候选产品是药物洗脱泪点塞OTX-DP和被插入到一个自然的开口叫坐落在靠近鼻子的眼睑的内侧部分的泪点OTX-TP。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局，或FDA批准的治疗药物对眼睛提供持续给药目的。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.018559},{"month":2,"riseRate":0.8,"avgChangeRate":0.25544},{"month":3,"riseRate":0.5,"avgChangeRate":0.026181},{"month":4,"riseRate":0.5,"avgChangeRate":-0.051966},{"month":5,"riseRate":0.6,"avgChangeRate":0.007801},{"month":6,"riseRate":0.4,"avgChangeRate":0.015343},{"month":7,"riseRate":0.4,"avgChangeRate":-0.050859},{"month":8,"riseRate":0.545455,"avgChangeRate":0.0647},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.0952},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.083937},{"month":11,"riseRate":0.636364,"avgChangeRate":0.142946},{"month":12,"riseRate":0.5,"avgChangeRate":0.089348}],"exchange":"NASDAQ","name":"Ocular Therapeutix","nameEN":"Ocular Therapeutix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocular Therapeutix,OCUL,Ocular Therapeutix股票,Ocular Therapeutix股票老虎,Ocular Therapeutix股票老虎国际,Ocular Therapeutix行情,Ocular Therapeutix股票行情,Ocular Therapeutix股价,Ocular Therapeutix股市,Ocular Therapeutix股票价格,Ocular Therapeutix股票交易,Ocular Therapeutix股票购买,Ocular Therapeutix股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}